CytoMed Therapeutics Stock (NASDAQ: GDTC) stock price, news, charts, stock research, profile.
Open | $2.170 |
Close | $2.170 |
Volume / Avg. | 2.911K / 46.508K |
Day Range | 2.170 - 2.170 |
52 Wk Range | 1.920 - 9.250 |
Market Cap | $25.134M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 0.54% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of CytoMed Therapeutics (NASDAQ: GDTC) through any online brokerage.
Other companies in CytoMed Therapeutics’s space includes: Galecto (NASDAQ:GLTO), OncoCyte (NASDAQ:OCX), Lumos Pharma (NASDAQ:LUMO), Sensei Biotherapeutics (NASDAQ:SNSE) and Indaptus Therapeutics (NASDAQ:INDP).
The latest price target for CytoMed Therapeutics (NASDAQ: GDTC) was reported by Benchmark on Monday, December 4, 2023. The analyst firm set a price target for 5.00 expecting GDTC to rise to within 12 months (a possible 129.36% upside). 2 analyst firms have reported ratings in the last year.
The stock price for CytoMed Therapeutics (NASDAQ: GDTC) is $2.18 last updated March 27, 2024 at 9:29 AM EDT.
There are no upcoming dividends for CytoMed Therapeutics.
CytoMed Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for CytoMed Therapeutics.
CytoMed Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.